Sacrix has developed the third iteration of its SacroFuse threaded compression device for immediate stabilization of the sacroiliac joint for pain relief and fusion.
The new design is a screw and cage hybrid with three different thread combinations. It is self-drilling, self-tapping and compresses across the sacroiliac joint.
Sacrix has allowed more space for graft containment equivalent to over 1cc, which is the largest volume of space for bone graft with this device, while maintaining biomechanical strength and increased pull-out strength over its previous design. Instrumentation is now simplified to allow for a 2-step technique with a 1.5cm incision, 100% percutaneous under fluoroscopy and bloodless.
Oscar Herrera, Senior Engineer and Product Manager of SacroFuse, said, “This new hybrid implant is designed to ease insertion and maximize osteointegration. Improvements to instrumentation supporting the efficient technique and a “letter sized” footprint system case punctuate the release. These updates will enhance the user experience, while offering a safe, effective and simple solution to Sacroiliac Joint dysfunction.”
Sacrix has developed the third iteration of its SacroFuse threaded compression device for immediate stabilization of the sacroiliac joint for pain relief and fusion.
The new design is a screw and cage hybrid with three different thread combinations. It is self-drilling, self-tapping and compresses across the sacroiliac joint.
Sacrix has...
Sacrix has developed the third iteration of its SacroFuse threaded compression device for immediate stabilization of the sacroiliac joint for pain relief and fusion.
The new design is a screw and cage hybrid with three different thread combinations. It is self-drilling, self-tapping and compresses across the sacroiliac joint.
Sacrix has allowed more space for graft containment equivalent to over 1cc, which is the largest volume of space for bone graft with this device, while maintaining biomechanical strength and increased pull-out strength over its previous design. Instrumentation is now simplified to allow for a 2-step technique with a 1.5cm incision, 100% percutaneous under fluoroscopy and bloodless.
Oscar Herrera, Senior Engineer and Product Manager of SacroFuse, said, “This new hybrid implant is designed to ease insertion and maximize osteointegration. Improvements to instrumentation supporting the efficient technique and a “letter sized” footprint system case punctuate the release. These updates will enhance the user experience, while offering a safe, effective and simple solution to Sacroiliac Joint dysfunction.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
